<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="figure" id="fig3" orientation="portrait" position="float">
 <label>Figure 3.</label>
 <caption>
  <p>
   <bold>CD57
    <sup>+</sup>KLRG1
    <sup>+</sup> T cells are expanded in CMV
    <sup>+</sup> young adults and negatively correlate with vaccine responses.
   </bold>
   <bold>(A and B)</bold> Frequency of CD57
   <sup>+</sup>KLRG1
   <sup>+</sup> double-positive cells within total CD4
   <sup>+</sup> T cells (A) and total CD8
   <sup>+</sup> T cells (B). Kruskal–Wallis analyses with Dunn’s post-comparison tests. **, P &lt; 0.01; ***, P &lt; 0.001. Medians shown for column graphs. Error bars indicate IQRs. 
   <bold>(C)</bold> Geomean subsets based on the expression of CD57 and KLRG1 in total CD4
   <sup>+</sup> (top row) or CD8
   <sup>+</sup> (bottom row) T cells in each group. 
   <bold>(D)</bold> Geomean subsets based on the expression of CD57 and KLRG1 in CD27
   <sup>−</sup>CD28
   <sup>−</sup>CD4
   <sup>+</sup> (top row) or CD27
   <sup>−</sup>CD28
   <sup>−</sup>CD8
   <sup>+</sup> (bottom row) T cells in each group. 
   <bold>(E and F)</bold> Relationship between the proportion of CD57
   <sup>+</sup>KLRG1
   <sup>+</sup> double-positives within CD4
   <sup>+</sup> T cells and peak antibody responses measured by ELISA (E) and peak T cell responses against Ebola GP measured by IFN-γ ELISPOT (F). Spearman’s rank analyses. UK CMV
   <sup>−</sup>
   <italic>n</italic> = 8, UK CMV
   <sup>+</sup>
   <italic>n</italic> = 8, Senegal 
   <italic>n</italic> = 27. SFC, spot-forming cell.
  </p>
 </caption>
 <graphic xlink:href="JEM_20200004_Fig3" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
